The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.
Gujarat Themis Biosyn has reported total income of Rs.93.82 crores for FY 2020-21
Dr Christiane Hamacher, has stepped down as the MD of Biocon Biologics and will be succeeded by Dr Arun Chandavarkar.
Medical experts point to a growing body of research linking energy drinks to liver injury
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The innovation is particularly suited for bone and cartilage repair
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
The company said it is supporting the ongoing investigation and reiterated its commitment to patient safety.
Subscribe To Our Newsletter & Stay Updated
